Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results

The findings from the UK proceedings were supported by a 2nd interventional proceedings from Italy delivered astatine the aforesaid conference. Both results stress the request for expanded security sum of continuous glucose monitoring successful European nations wherever Libre has not been officially covered.

Although nary determination is expected precise soon, the CMS is reasoning astir expanding compensation successful the US. According to Benchmark, arsenic 1 of the apical providers of continuous glucose monitoring, Abbott Laboratories (NYSE:ABT) is well-positioned to nett from this development.

Abbott Laboratories (NYSE:ABT) is simply a starring planetary healthcare institution that manufactures a wide scope of branded generic medications, aesculapian devices, diagnostics, and nutritional items.

While we admit the imaginable of ABT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.